Korea United Pharm Inc
KRX:033270

Watchlist Manager
Korea United Pharm Inc Logo
Korea United Pharm Inc
KRX:033270
Watchlist
Price: 20 550 KRW -1.44%
Market Cap: 302.3B KRW
Have any thoughts about
Korea United Pharm Inc?
Write Note

Korea United Pharm Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Korea United Pharm Inc
Total Equity Peer Comparison

Comparables:
000100
326030
008930
128940
S
000250

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Korea United Pharm Inc
KRX:033270
Total Equity
â‚©386.6B
CAGR 3-Years
10%
CAGR 5-Years
10%
CAGR 10-Years
10%
Yuhan Corp
KRX:000100
Total Equity
â‚©2.1T
CAGR 3-Years
3%
CAGR 5-Years
5%
CAGR 10-Years
5%
SK Biopharmaceuticals Co Ltd
KRX:326030
Total Equity
â‚©283.7B
CAGR 3-Years
-9%
CAGR 5-Years
37%
CAGR 10-Years
N/A
Hanmi Science Co Ltd
KRX:008930
Total Equity
â‚©832.2B
CAGR 3-Years
7%
CAGR 5-Years
5%
CAGR 10-Years
7%
Hanmi Pharm Co Ltd
KRX:128940
Total Equity
â‚©1.1T
CAGR 3-Years
12%
CAGR 5-Years
8%
CAGR 10-Years
7%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Total Equity
â‚©276.5B
CAGR 3-Years
15%
CAGR 5-Years
13%
CAGR 10-Years
11%

See Also

What is Korea United Pharm Inc's Total Equity?
Total Equity
386.6B KRW

Based on the financial report for Jun 30, 2024, Korea United Pharm Inc's Total Equity amounts to 386.6B KRW.

What is Korea United Pharm Inc's Total Equity growth rate?
Total Equity CAGR 10Y
10%

Over the last year, the Total Equity growth was 8%. The average annual Total Equity growth rates for Korea United Pharm Inc have been 10% over the past three years , 10% over the past five years , and 10% over the past ten years .

Back to Top